Trans-Apical Transcatheter Aortic Valve Replacement in a Dialysis Patient with Systolic Heart Failure

Akira Oshima; Teruhiko Imamura; Hiroshi Onoda; Yohei Ueno; Ryuichi Ushijima; Mitsuo Sobajima; Nobuyuki Fukuda; Shigeki Yokoyama; Toshio Doi; Kazuaki Fukahara; Hiroshi Ueno; Koichiro Kinugawa

doi:10.3390/medicina58030347

Trans-Apical Transcatheter Aortic Valve Replacement in a Dialysis Patient with Systolic Heart Failure

Medicina (Kaunas). 2022 Feb 24;58(3):347. doi: 10.3390/medicina58030347.

Affiliations

¹ The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
² Department of Surgery 1, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.

Abstract

Mortality and morbidity remain high following transcatheter aortic valve replacement (TAVR) in dialysis patients or those with low left ventricular ejection fraction. Therapeutic strategy for those with these comorbidities remains unestablished. We had a dialysis patient with peripheral artery disease and low left ventricular ejection fraction, who received successfully scheduled trans-apical TAVR following sufficient reverse remodeling by 3-month optimal medical therapy. Our strategy should be validated in a larger robust cohort.

Keywords: aortic stenosis; heart failure; valvular disease.

Publication types

Case Reports

MeSH terms

Aortic Valve Stenosis* / complications
Aortic Valve Stenosis* / surgery
Heart Failure, Systolic* / complications
Heart Failure, Systolic* / surgery
Humans
Renal Dialysis
Stroke Volume
Transcatheter Aortic Valve Replacement*
Ventricular Function, Left